Surrozen Inc (SRZN)

Surrozen Inc (SRZN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $276M; returns 1 day -1.0%, 1 week +8.7%, 1 year +85.9%.

Surrozen Inc. (SRZN) is a clinical-stage biotechnology company focused on pioneering Wnt-based therapeutics for tissue repair and regeneration, having recently pivoted its core strategy to concentrate on severe ophthalmic diseases.

Groups SRZN belongs to

• Biotechnology
• Clinical Stage Biotech
• Regenerative Medicine
• Clinical Stage
• Ophthalmology
• Healthcare
• Antibody Therapeutics
• Bispecific Antibodies
• Strategic Pivot
• Life Sciences
• Biopharmaceutical

SRZN financial model: income statement, cash flow and balance sheet